NeoPhore in a £6M bridge funding round.
16 January 2023
16 January 2023
Total investments received (USD): 40.71M
Round value (USD): 7.44M
Company: NeoPhore
Industry: BiotechHealth services
Related deals
Enhanc3D in a $7.7M series A extension with Business Growth Fund, Parkwalk Advisors and Bioqube Ventures
Investments
18 September 2025
Nuclide Therapeutics raised £5 million seed investment round w/ Marathon Beteiligungs AG.
Investments
12 September 2025
Signatur Biosciences closed a $7 million seed round led by The Discovery Lab of IBA, joined by Noshaq and YC
Investments
12 May 2025
Ovo Labs raised £4M in a seed round co-led by LocalGlobe and Creator Fund in the UK
Investments
10 April 2025
Netherlands
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Portugal
Spain